Remove Collective Remove Conditions Remove Safety Remove Treatment
article thumbnail

Survey: Nearly One in Five Pediatric Cerebral Palsy Patients Use CBD

Veriheal

Treatment plans are customized to each individual’s needs. Instead of directly surveying the young patients, they reached out to their caregivers – the individuals who deeply understand the daily routines, challenges, and treatments of these children.

Patients 113
article thumbnail

New Study Shows Medical Cannabis Syqe Inhaler Significantly Reduced Pain in Neuropathy Patients

Veriheal

Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. The team included 143 patients in their research and evaluated pain intensity through the use of a numeric pain scale from the baseline to 120 days post-treatment initiation.

Patients 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. The search included studies through 11-May-2020. Introduction. Search strategy.

Safety 52
article thumbnail

Webinar 9 December: Ethics, Safety, and Abuse in Psychedelic Medicine

Cannabis Law Report

Ethics, Safety, and Abuse in Psychedelic Medicine. She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS. She is the director of Drug Education at Students for Sensible Drug Policy and co-founder and director at Sana Healing Collective.

Safety 52
article thumbnail

Sapphire Medical Clinics expands patient access to cheapest medical cannabis fees in UK

Cannabis Law Report

This reduction in prices will make the clinic the cheapest option for many patients looking to receive medical cannabis treatments for a wide variety of conditions and illnesses. Sapphire-Pricing-and-Timelines-v1.4. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52
article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain.

article thumbnail

ElleVet Sciences Publishes Safety Study On CBD For Animals

Cannabis Law Report

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45